BR0010934A - Peptìdeos n-alquilados possuindo atividade antiangiogênica - Google Patents

Peptìdeos n-alquilados possuindo atividade antiangiogênica

Info

Publication number
BR0010934A
BR0010934A BR0010934-7A BR0010934A BR0010934A BR 0010934 A BR0010934 A BR 0010934A BR 0010934 A BR0010934 A BR 0010934A BR 0010934 A BR0010934 A BR 0010934A
Authority
BR
Brazil
Prior art keywords
xaa
antiangiogenic activity
alkylated peptides
alkylated
peptides
Prior art date
Application number
BR0010934-7A
Other languages
English (en)
Inventor
Fortuna Haviv
Jack Henkin
Michael F Bradley
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR0010934A publication Critical patent/BR0010934A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"PEPTìDEOS N-ALQUILADOS POSSUINDO ATIVIDADE ANTIANGIOGêNICA". Peptídeos N-alquilados da fórmula (I) Xaa~ 1~-, Xaa~ 2~-, Xaa~ 3~-, Xaa~ 4~-, Xaa~ 5~-, Xaa~ 6~-, Xaa~ 7~-, Xaa~ 8~-, Xaa~ 9~, Xaa~ 10~-, Xaa~ 11~ são úteis para inibição da angiogenese. Também são reveladas composições para inibir a angiogenese e processos para inibir angiogenese em mamíferos.
BR0010934-7A 1999-11-22 2000-11-22 Peptìdeos n-alquilados possuindo atividade antiangiogênica BR0010934A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44709999A 1999-11-22 1999-11-22
US70264900A 2000-10-31 2000-10-31
PCT/US2000/032105 WO2001038397A1 (en) 1999-11-22 2000-11-22 N-alkylated peptides having antiangiogenic activity

Publications (1)

Publication Number Publication Date
BR0010934A true BR0010934A (pt) 2002-12-17

Family

ID=27034850

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010934-7A BR0010934A (pt) 1999-11-22 2000-11-22 Peptìdeos n-alquilados possuindo atividade antiangiogênica

Country Status (10)

Country Link
EP (1) EP1242455A1 (pt)
JP (1) JP2003514920A (pt)
AR (1) AR026901A1 (pt)
AU (1) AU1791301A (pt)
BR (1) BR0010934A (pt)
CA (1) CA2386893A1 (pt)
CO (1) CO5261544A1 (pt)
HK (1) HK1050902A1 (pt)
MX (1) MXPA02005139A (pt)
WO (1) WO2001038397A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183242A1 (en) * 2001-04-11 2002-12-05 Jack Henkin Peptide antiangiogenic drugs
US20030125259A1 (en) 2001-10-31 2003-07-03 Fortuna Haviv Octa- and nonapeptides having antiangiogenic activity
US7169888B2 (en) 2001-10-31 2007-01-30 Abbott Laboratories Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
US7001984B2 (en) 2001-10-31 2006-02-21 Abbott Laboratories Di-, tri-, and tetra-peptides having antiangiogenic activity
US20030119746A1 (en) * 2001-10-31 2003-06-26 Fortuna Haviv Hepta-and octapeptides having antiangiogenic activity
US7067490B2 (en) 2001-10-31 2006-06-27 Abbott Laboratories Hepta-, Octa-and nonapeptides having antiangiogenic activity
US7037897B2 (en) 2001-10-31 2006-05-02 Abbott Laboratories TRI-, TETRA-, and penta-peptides having antiangiogenic activity
US7122625B2 (en) 2001-10-31 2006-10-17 Abbott Laboratories Hexa-, hepta-, and octapeptides having antiangiogenic activity
US20030228365A1 (en) * 2002-06-07 2003-12-11 Fortuna Haviv Pharmaceutical formulation
JP5167473B2 (ja) 2005-03-03 2013-03-21 コヴェックス・テクノロジーズ・アイルランド・リミテッド 抗血管新生化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001502293A (ja) * 1996-03-05 2001-02-20 トーレイ パインズ インスティテュート フォー モレキュラー スタディーズ 選択的にｎ―アルキル化されたペプチド模倣的コンビナトリアルライブラリおよびその中の化合物
IL126626A0 (en) * 1996-05-03 1999-08-17 Abbott Lab Novel antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis
PT918795E (pt) * 1997-03-17 2005-02-28 Abbott Lab Droga antiangiogenica para tratar cancro artrite e retinopatia

Also Published As

Publication number Publication date
CO5261544A1 (es) 2003-03-31
EP1242455A1 (en) 2002-09-25
AU1791301A (en) 2001-06-04
MXPA02005139A (es) 2004-08-23
WO2001038397A1 (en) 2001-05-31
HK1050902A1 (zh) 2003-07-11
JP2003514920A (ja) 2003-04-22
AR026901A1 (es) 2003-03-05
CA2386893A1 (en) 2001-05-31

Similar Documents

Publication Publication Date Title
DK1200418T3 (da) Nematodicide trifluorbutener
ZA975443B (en) Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides.
GB0011203D0 (en) Chemical compounds
BR9801652A (pt) Resorcinil-triazinas
MXPA02012042A (es) Compuestos efectivos como agonistas de beta-2-adrenorreceptor, y como inhibidores de pde4.
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
BR0010934A (pt) Peptìdeos n-alquilados possuindo atividade antiangiogênica
MXPA01011606A (es) Terapia anti-inflamatoria para infeccion mediada por inflamacion.
HK1050012A1 (en) Peptides having antiangiogenic activity
BR9902084A (pt) Heterociclos.
DK1204659T3 (da) Serotonerge benzofuraner
ZA979647B (en) Heterocyclic compounds, compositions and uses.
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
DE60011677D1 (en) Tryptase-inhibitoren
SI1244614T1 (en) Tryptase inhibitors
ZA979650B (en) Heterocyclic compounds, compositions and uses.
ZA979645B (en) Heterocyclic compounds, compositions and uses.
MXPA03001986A (es) Composiciones antitromboticas.
DE69807200D1 (de) Inklusionskomplexe in waessriger loesung
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
ES2183543T3 (es) Derivado de tiocolchicosida, su preparacion y su aplicacion en terapeutica.
TR200200558T2 (tr) Yeni bileşimler F-15078
ATE227571T1 (de) Thrombin inhibitoren
UA32973A (uk) Комбінована мазь для лікування ран "нітафен"
IT1315249B1 (it) Composizioni farmaceutiche contenenti farmaci antiinfiammatori

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTA A 6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.